Negar Shamshiri

• Led UK market launch , transitioning the company from new entrant to established player, opening 6 new accounts in the south of England
• Developed and executed a go-to-market strategy , including clinical pathways and NHS business cases
• Built relationships with ENT consultants, sleep specialists, and KOLs to drive adoption
• Opened and managed multiple key accounts, generating early-stage revenue of 1.1 million GBP
• Delivered high-level technical clinical training to multidisciplinary teams, ensuring safe product adoption
• Collaborated with US and European teams to localise the commercial strategy

Key Achievements:

• Established the first operational NHS Inspire therapy pathway
• Created scalable business case templates used nationally
• Positioned UK as a priority growth market

• Managed 4 key hospital accounts , delivering high customer satisfaction
• Finished FY 2024 at 119% of target
• Increased market share by 20% within the territory
• Identified and converted new business opportunities through market analysis
• Supported product launch initiatives and strategic positioning

• Assisted in achieving £3.85m in revenue, surpassing targets by 156%.
• Helped generate £2m+ in revenue within six months (2022–2023).
• Expanded market share from 53% to 60%.
• Supported leadership team in securing #1 rank on leadership board.
• Organised product launches for Peristeen Plus Cone Catheter.
• Provided clinical education and aided patient adoption.
• Fostered relationships across NHS and private sector.

• Provided patient-centred support in managing complex clinical cases.
• Facilitated educational programmes and encouraged teamwork among diverse specialists.
• Established trust and credibility with stakeholders through consistent clinical practice.

• Consistent overachievement (up to 123%)
• Won major contracts, including HCA Healthcare
• Grew market share significantly (26% → 39%)